BOTALYS
PrivateLast Round
Series B
Oct 4, 2022
Total Funding Raised
$11.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BOTALYS operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Series B round in October 2022.
BOTALYS is a biotechnology company that produces potent and pure botanical ingredients for the nutraceutical and cosmetic industries using a proprietary vertical farming technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOTALYS Comparables
Compare BOTALYS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ljusgårda AB | 83% | |
| Plant Advanced Technologies PAT | 82% | |
| Interstellar Lab | 79% |
For institutional investors. Book with your work email.
BOTALYS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 4, 2022 | ||||
| Grant | May 31, 2021 | ||||
| Grant | Mar 1, 2019 | ||||
| VC Round | Jan 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BOTALYS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Société Régionale d'Investissement de Wallonie | Series B |
| Air Liquide Venture Capital | Series B |
| VIVES Partners | VC Round |
| Wapinvest | Series B, Seed |
| European Union | Grant |
| The Yield Lab | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 163% MoM.
- Jan 22, 2026
Added L’Oréal Group, a beauty & personal care company, as a customer.
For institutional investors. Book with your work email.
BOTALYS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BOTALYS's valuation, stock price, and market status.
Is BOTALYS a public or private company?
BOTALYS is a private company.
What is the current stock price of BOTALYS?
BOTALYS is a private company, so its shares have no public market price. Caplight tracks BOTALYS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BOTALYS worth (valuation)?
Valuation information for BOTALYS is not publicly available.
Can I buy BOTALYS stock?
BOTALYS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BOTALYS's last funding round?
BOTALYS's most recent funding round was Series B on October 4, 2022.
Who are the main investors in BOTALYS?
Key investors in BOTALYS include Air Liquide Venture Capital, VIVES Partners.
Will BOTALYS IPO soon?
No public IPO plans have been announced for BOTALYS.
How can I track BOTALYS secondary market activity?
Caplight tracks bids, offers, and trades in BOTALYS's shares on secondary markets.